Regulating pharmaceutical companies’ financial largesse
Abstract Nissanholtz-Gannot and Yenkellevich (NGY) explore the impact of a 2010 amendment to the Israeli National Health Insurance Law that requires annual reporting of payments from pharmaceutical companies (PCs) to doctors and healthcare organizations. The amendment was adopted to ensure transpare...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-05-01
|
| Series: | Israel Journal of Health Policy Research |
| Online Access: | http://link.springer.com/article/10.1186/s13584-018-0220-5 |